AAAAAA

   
Results: 1-25 | 26-50 | 51-66
Results: 1-25/66
ANTIPLATELET AGENTS IN CARDIOVASCULAR AND CEREBROVASCULAR DISEASES
Authors: BREDDIN HK
Citation: Hk. Breddin, ANTIPLATELET AGENTS IN CARDIOVASCULAR AND CEREBROVASCULAR DISEASES, Clinical and applied thrombosis/hemostasis, 4(2), 1998, pp. 87-95
A SUPERSULFATED LOW-MOLECULAR-WEIGHT HEPARIN (IK-SSH) INCREASES PLASMA-LEVELS OF FREE AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HUMANS
Authors: KAISER B GLUSA E HOPPENSTEADT DA BREDDIN HK AMIRAL J FAREED J
Citation: B. Kaiser et al., A SUPERSULFATED LOW-MOLECULAR-WEIGHT HEPARIN (IK-SSH) INCREASES PLASMA-LEVELS OF FREE AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HUMANS, Blood coagulation & fibrinolysis, 9(6), 1998, pp. 517-523
EFFICACY OF A LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED INTRAVENOUSLYOR SUBCUTANEOUSLY IN COMPARISON WITH INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS
Authors: KIRCHMAIER CM WOLF H SCHAFER H EHLERS B BREDDIN HK
Citation: Cm. Kirchmaier et al., EFFICACY OF A LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED INTRAVENOUSLYOR SUBCUTANEOUSLY IN COMPARISON WITH INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS, International angiology, 17(3), 1998, pp. 135-145
EXPERIMENTAL STUDIES ON THE INTERACTION OF LW10082 (APROSULPHATE) WITH OTHER ANTITHROMBOTIC AGENTS IN LASER-INDUCED THROMBOSIS
Authors: GIEDROJC J RADZIWON P KLIMIUK MB BREDDIN HK
Citation: J. Giedrojc et al., EXPERIMENTAL STUDIES ON THE INTERACTION OF LW10082 (APROSULPHATE) WITH OTHER ANTITHROMBOTIC AGENTS IN LASER-INDUCED THROMBOSIS, Lasers in medical science, 13(2), 1998, pp. 132-136
PLATELET-ADHESION BY PATIENTS WITH THROMBASTHENIA-GLANZMANN, GIANT PLATELET THROMBOCYTOPATHY AND STORAGE POOL DISEASE ON EXTRACELLULAR-MATRIX
Authors: HAGENDORFF KB WESTRUP D MULLER M BREDDIN HK SEIFRIED E KIRCHMAIER CM
Citation: Kb. Hagendorff et al., PLATELET-ADHESION BY PATIENTS WITH THROMBASTHENIA-GLANZMANN, GIANT PLATELET THROMBOCYTOPATHY AND STORAGE POOL DISEASE ON EXTRACELLULAR-MATRIX, Thrombosis and haemostasis, 1997, pp. 269-269
MONITORING OF THE ANTICOAGULANT EFFECTS OF PEG-HIRUDIN ADMINISTERED AS A CONTINUOUS 24-HOUR INFUSION FOLLOWING AN IV BOLUS INJECTION IN HEALTHY-VOLUNTEERS USING THE ECARIN CLOTTING TIME
Authors: ESSLINGER HU DUBBERS K RADZIWON P BREDDIN HK
Citation: Hu. Esslinger et al., MONITORING OF THE ANTICOAGULANT EFFECTS OF PEG-HIRUDIN ADMINISTERED AS A CONTINUOUS 24-HOUR INFUSION FOLLOWING AN IV BOLUS INJECTION IN HEALTHY-VOLUNTEERS USING THE ECARIN CLOTTING TIME, Thrombosis and haemostasis, 1997, pp. 1135-1135
ANTITHROMBOTIC AND THROMBOLYTIC ACTIVITY OF HEPARINS IN A RAT MODEL OF LASER-INDUCED THROMBOSIS
Authors: KRUPINSKI K GIEDROJC J CZUK J BREDDIN HK BIELAWIEC M
Citation: K. Krupinski et al., ANTITHROMBOTIC AND THROMBOLYTIC ACTIVITY OF HEPARINS IN A RAT MODEL OF LASER-INDUCED THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 1214-1214
A SUPERSULFATED LOW-MOLECULAR-WEIGHT HEPARIN (SSH-14) STRONGLY INCREASES TFPI LEVELS AFTER SC ADMINISTRATION IN HUMANS
Authors: GLUSA E KAISER B HOPPENSTEADT D FAREED J BREDDIN HK AMIRAL J
Citation: E. Glusa et al., A SUPERSULFATED LOW-MOLECULAR-WEIGHT HEPARIN (SSH-14) STRONGLY INCREASES TFPI LEVELS AFTER SC ADMINISTRATION IN HUMANS, Thrombosis and haemostasis, 1997, pp. 1671-1671
PHARMACODYNAMICS OR THE ANTIPLATELET EFFECTS OF 2 GLYCOPROTEIN IIB IIIA TARGETING ANTIBODIES IN A PRIMATE MODEL/
Authors: FAREED J YANG L FU K HOPPENSTEADT D LEWIS BE BREDDIN HK
Citation: J. Fareed et al., PHARMACODYNAMICS OR THE ANTIPLATELET EFFECTS OF 2 GLYCOPROTEIN IIB IIIA TARGETING ANTIBODIES IN A PRIMATE MODEL/, Thrombosis and haemostasis, 1997, pp. 2713-2713
NEW ASPECTS ON HIRUDIN
Authors: BREDDIN HK
Citation: Hk. Breddin, NEW ASPECTS ON HIRUDIN, Die medizinische Welt, 48(2), 1997, pp. 64-66
ARE THE CURRENTLY AVAILABLE LOW-MOLECULAR-WEIGHT HEPARINS DIFFERENT DRUGS
Authors: FAREED J JESKE W HOPPENSTEADT D WALENGA JM BREDDIN HK HAAS S STRANO A
Citation: J. Fareed et al., ARE THE CURRENTLY AVAILABLE LOW-MOLECULAR-WEIGHT HEPARINS DIFFERENT DRUGS, Blood, 90(10), 1997, pp. 3221-3221
A LOW-MOLECULAR-WEIGHT HYPERSULFATED HEPARIN DERIVATIVE WITH LOW ANTICOAGULANT ACTIVITY RELEASES VASCULAR TISSUE FACTOR PATHWAY INHIBITOR (TFPI) - STUDIES ON TOTAL AND FREE TFPI
Authors: KAISER B GLUSA E LIETZ H HOPPENSTEADT DA BREDDIN HK AMIRAL J FAREED J
Citation: B. Kaiser et al., A LOW-MOLECULAR-WEIGHT HYPERSULFATED HEPARIN DERIVATIVE WITH LOW ANTICOAGULANT ACTIVITY RELEASES VASCULAR TISSUE FACTOR PATHWAY INHIBITOR (TFPI) - STUDIES ON TOTAL AND FREE TFPI, Blood, 90(10), 1997, pp. 3238-3238
A RECOMBINANT HIRUDIN (IK-HIRO2) IN HEALTHY-VOLUNTEERS .2. EFFECTS ONPLATELET-ADHESION AND PLATELET-INDUCED THROMBIN GENERATION TIME
Authors: SCHENK JF GLUSA E RADZIWON P BUTTI A MARKWARDT F BREDDIN HK
Citation: Jf. Schenk et al., A RECOMBINANT HIRUDIN (IK-HIRO2) IN HEALTHY-VOLUNTEERS .2. EFFECTS ONPLATELET-ADHESION AND PLATELET-INDUCED THROMBIN GENERATION TIME, Haemostasis, 26(4), 1996, pp. 187-194
A RECOMBINANT HIRUDIN (IK-HIRO2) IN HEALTHY-VOLUNTEERS .1. EFFECTS ONCOAGULATION PARAMETERS AND BLEEDING-TIME
Authors: SCHENK JF GLUSA E RADZIWON P BUTTI A MARKWARDT F BREDDIN HK
Citation: Jf. Schenk et al., A RECOMBINANT HIRUDIN (IK-HIRO2) IN HEALTHY-VOLUNTEERS .1. EFFECTS ONCOAGULATION PARAMETERS AND BLEEDING-TIME, Haemostasis, 26(3), 1996, pp. 140-149
PATHOPHYSIOLOGY OF THROMBOEMBOLISM AND ITS MODULATION BY LOW-MOLECULAR-WEIGHT HEPARINS
Authors: BREDDIN HK
Citation: Hk. Breddin, PATHOPHYSIOLOGY OF THROMBOEMBOLISM AND ITS MODULATION BY LOW-MOLECULAR-WEIGHT HEPARINS, Seminars in thrombosis and hemostasis, 22, 1996, pp. 25-27
CORONARY HEART-DISEASE, UNSTABLE ANGINA, PTCA - NEW INDICATIONS FOR LOW-MOLECULAR-WEIGHT HEPARINS
Authors: BREDDIN HK
Citation: Hk. Breddin, CORONARY HEART-DISEASE, UNSTABLE ANGINA, PTCA - NEW INDICATIONS FOR LOW-MOLECULAR-WEIGHT HEPARINS, Thrombosis research, 81(2), 1996, pp. 47-51
THROMBIN INHIBITION ENHANCES ASPIRIN-INDUCED BLEEDING-TIME PROLONGATION
Authors: BREDDIN HK RADZIWON P ESSLINGER HU
Citation: Hk. Breddin et al., THROMBIN INHIBITION ENHANCES ASPIRIN-INDUCED BLEEDING-TIME PROLONGATION, Circulation, 94(8), 1996, pp. 1561-1561
PHARMACODYNAMICS OF THE ANTIPLATELET EFFECTS OF 2 GLYCOPROTEIN-IIB IIIA TARGETING ANTIBODIES IN A PRIMATE MODEL/
Authors: FAREED J YANG L FU K HOPPENSTEADT D BREDDIN HK
Citation: J. Fareed et al., PHARMACODYNAMICS OF THE ANTIPLATELET EFFECTS OF 2 GLYCOPROTEIN-IIB IIIA TARGETING ANTIBODIES IN A PRIMATE MODEL/, Blood, 88(10), 1996, pp. 656-656
EFFECTS OF PROSTAGLANDIN E(1) ON PLATELET -FUNCTION AND COAGULATION PARAMETERS IN PATIENTS WITH CHRONIC PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Authors: SCHENK JF RADZIWON P BOCZKOWSKARADZIWON B BREDDIN HK
Citation: Jf. Schenk et al., EFFECTS OF PROSTAGLANDIN E(1) ON PLATELET -FUNCTION AND COAGULATION PARAMETERS IN PATIENTS WITH CHRONIC PERIPHERAL ARTERIAL OCCLUSIVE DISEASE, Perfusion, 8(10), 1995, pp. 332
SPONTANEOUS PLATELET-AGGREGATION AS A PREDICTIVE RISK FACTOR FOR VASCULAR OCCLUSIONS IN HEALTHY-VOLUNTEERS - RESULTS OF THE HAPARG-STUDY
Authors: BREDDIN HK KIRCHMAIER CM BITTNER M KRZYWANEK HJ MICHAELIS J
Citation: Hk. Breddin et al., SPONTANEOUS PLATELET-AGGREGATION AS A PREDICTIVE RISK FACTOR FOR VASCULAR OCCLUSIONS IN HEALTHY-VOLUNTEERS - RESULTS OF THE HAPARG-STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 954-954
COMPARISON OF TISSUE FACTOR PATHWAY INHIBITOR STIMULATION BY HEPARIN IN CULTURED HUMAN ENDOTHELIAL AND SMOOTH-MUSCLE CELLS
Authors: BECKERHAGENDORFF K WESTRUP D WEISENSEE D BREDDIN HK SEIFRIED E KIRCHMAIER CM
Citation: K. Beckerhagendorff et al., COMPARISON OF TISSUE FACTOR PATHWAY INHIBITOR STIMULATION BY HEPARIN IN CULTURED HUMAN ENDOTHELIAL AND SMOOTH-MUSCLE CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 1260-1260
A SIMPLE METHOD FOR THE MEASUREMENT OF FREE TFPI IN PLASMA
Authors: RADZIWON P BOCZKOWSKARADZIWON B SCHENK J FAREED J BREDDIN HK
Citation: P. Radziwon et al., A SIMPLE METHOD FOR THE MEASUREMENT OF FREE TFPI IN PLASMA, Thrombosis and haemostasis, 73(6), 1995, pp. 1261-1261
EXPERIMENTAL STUDIES ON THE INTERACTION OF LW-10082 (APROSULATE) WITHOTHER ANTITHROMBOTIC AGENTS IN LASER-INDUCED THROMBOSIS
Authors: GIEDROJC J KRUPINSKI K JAROMIN J BIELAWIEC M BREDDIN HK
Citation: J. Giedrojc et al., EXPERIMENTAL STUDIES ON THE INTERACTION OF LW-10082 (APROSULATE) WITHOTHER ANTITHROMBOTIC AGENTS IN LASER-INDUCED THROMBOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1341-1341
COMPARATIVE-STUDY ON THE EFFECT OF DIFFERENT ANTITHROMBOTIC AGENTS ALONE AND TOGETHER WITH ASA ON THROMBUS FORMATION IN THE RAT THROMBOSIS MODEL AND PLATELET-ADHESION TO EXTRACELLULAR-MATRIX
Authors: KRUPINSKI K GIEDROJC J BREDDIN HK BIELAWIEC M
Citation: K. Krupinski et al., COMPARATIVE-STUDY ON THE EFFECT OF DIFFERENT ANTITHROMBOTIC AGENTS ALONE AND TOGETHER WITH ASA ON THROMBUS FORMATION IN THE RAT THROMBOSIS MODEL AND PLATELET-ADHESION TO EXTRACELLULAR-MATRIX, Thrombosis and haemostasis, 73(6), 1995, pp. 1342-1342
METHODS TO MONITOR THE EFFECTS OF GLYCOPROTEIN-IIB IIIA INHIBITORS AND THEIR INTERACTIONS WITH OTHER ANTITHROMBOTIC AGENTS/
Authors: BREDDIN HK BREDDIN H KIRCHMAIER CM KEPPLER S
Citation: Hk. Breddin et al., METHODS TO MONITOR THE EFFECTS OF GLYCOPROTEIN-IIB IIIA INHIBITORS AND THEIR INTERACTIONS WITH OTHER ANTITHROMBOTIC AGENTS/, Thrombosis and haemostasis, 73(6), 1995, pp. 1446-1446
Risultati: 1-25 | 26-50 | 51-66